kabutan

RaQualia Pharma Inc., July-September (3Q) Ordinary Profit Turns to Profit

Thu Nov 14, 2024 3:30 pm JST Earnings

4579 RaQualia Pharma Inc. 【J-GAAP】

Earnings Report

RaQualia Pharma Inc. <4579> [TSE-G] announced its financial results after the market closed on November 14th (15:30). The consolidated ordinary loss for the cumulative third quarter of the fiscal year ending December 2024 (January to September) expanded to a loss of 231 million yen (compared to a loss of 36 million yen in the same period last year).

Based on the third-quarter cumulative performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the October to December period (4Q) is expected to turn into a profit of 521 million yen (compared to a loss of 257 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit/loss turned to a profit of profit of 46 million yen (compared to a loss of 72 million yen in the same period last year). The operating profit/loss margin drastically improved from -17.7% in the same period last year to 13.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 1,904 501 676 467 22.3 74.8 Nov 11, 2022 J-GAAP
Jan - Sep, 2023 1,495 -108 -36 -117 -5.5 ー Nov 10, 2023 J-GAAP
Jan - Sep, 2024 2,369 -27 -231 -339 -15.7 ー Nov 14, 2024 J-GAAP
YoY +58.5% +75.0% -541.7% -189.7% -188.3%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 887 -314 -329 -348 -16.1 0 Feb 14, 2024 J-GAAP
Jul - Dec, 2024 Guidance 3,124 467 567 559 25.6 0 Aug 14, 2024 J-GAAP
YoY +252.2% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 2,918 866 904 723 34.5 0 Feb 14, 2023 J-GAAP
Dec, 2023 1,901 -337 -293 -323 -15.0 0 Feb 14, 2024 J-GAAP
Dec, 2024 Guidance 4,535 313 290 236 10.8 0 Feb 14, 2024 J-GAAP
YoY +138.6% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 481 -85 -72 -142 -6.6 -17.7 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 406 -229 -257 -206 -9.6 -56.4 Feb 14, 2024 J-GAAP
Jan - Mar, 2024 648 44 -77 -78 -3.6 6.8 May 15, 2024 J-GAAP
Apr - Jun, 2024 763 -198 -200 -245 -11.4 -26.0 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 958 127 46 -16 -0.7 13.3 Nov 14, 2024 J-GAAP
YoY +99.2% － － +88.7% +88.8%

Related Articles